Australia's Starpharma's launches COVID-19 antiviral nasal spray VIRALEZE in the UK
Therapeutics | News | 0 Comment | 01 Apr, 2021
Melbourne-based biotech Starpharma has launched its antiviral nasal spray VIRALEZE™ into the UK via a large nation...Read more
Gracell Bio leverages Lonza's expertise in CAR-T cell therapy manufacturing
Therapeutics | News | 0 Comment | 01 Apr, 2021
China based Gracell Biotechnologies Inc., a global clinical-stage biopharmaceutical company dedicated to discovering and...Read more
Singapore creates 3D models to fine-tune radiation dose for nasopharyngeal cancer
Therapeutics | News | 0 Comment | 31 Mar, 2021
Singapore, A*STAR’s Institute of Bioengineering and Nanotechnology (IBN) has teamed up with Singapore Institute of...Read more
Bright Peak Therapeutics and Ajinomoto to create novel immunocytokines
Therapeutics | News | 0 Comment | 26 Mar, 2021
Bright Peak Therapeutics Inc., a biotechnology company developing next-generation immunotherapies for cancer and autoimm...Read more
POSTECH produces artificial lung model using 3D printing
Therapeutics | News | 0 Comment | 25 Mar, 2021
Scientists at the Pohang University of Science and Technology (POSTECH) in South Korea have succeeded in producing ...Read more
Singapore SMART researchers develop rapid immune-profiling assay
Therapeutics | News | 0 Comment | 25 Mar, 2021
Researchers from Critical Analytics for Manufacturing Personalized-Medicine (CAMP), an Interdisciplinary Research...Read more
Singapore study reveals variation in SARS-CoV-2 neutralizing antibody longevity
Therapeutics | News | 0 Comment | 24 Mar, 2021
Scientists from Duke-NUS Medical School, the National Centre for Infectious Diseases (NCID) and the Agency for Science, ...Read more
Singapore develops AI platform to assess blood vessel anomalies
Therapeutics | News | 0 Comment | 24 Mar, 2021
An international team of scientists from Nanyang Technological University, Singapore (NTU Singapore), Brown Un...Read more
Australia invests $2.6 M in life-improving research for brain cancer survivors
Therapeutics | News | 0 Comment | 23 Mar, 2021
The Australian government is providing $2.6 million to researchers at the University of Melbourne to use the latest info...Read more
Singapore finds way to improve treatment outcomes for breast cancer
Therapeutics | News | 0 Comment | 19 Mar, 2021
Breast cancer is the most common cancer in women worldwide and the second most common cancer overall. Although...Read more
Cancer drug delivery system receives US FDA approval for trials
Therapeutics | News | 0 Comment | 18 Mar, 2021
A first-in-class cancer drug delivery system developed by Taiwan's National Health Research Institutes (NHRI) has receiv...Read more
Korea identifies genetic pathway that suppresses neurodegenerative diseases
Therapeutics | News | 0 Comment | 17 Mar, 2021
Nucleocytoplasmic transport (NCT) defects have been implicated in neurodegenerative diseases, such as C9ORF72-associated...Read more
Govt launches $15 M grant for development of innovative therapies for mental illness
Therapeutics | News | 0 Comment | 17 Mar, 2021
The Australian government is launching a $15 million competitive grant round to kick start Australian clinical trials ex...Read more
Singapore identifies chemotherapy-resistant cancers’ escape mechanism
Therapeutics | News | 0 Comment | 16 Mar, 2021
ETC-159, a made-in-Singapore anti-cancer drug that is currently in early phase clinical trials for use in a subset ...Read more
Fujitsu, Kyoto University build AI system to detect genetic disorders
Therapeutics | News | 0 Comment | 15 Mar, 2021
Fujitsu Limited and Kyoto University research group led by Professor Yasushi Okuno of the Kyoto University Graduate Scho...Read more
HSA approves first commercial CAR-T therapy by Novartis
Therapeutics | News | 0 Comment | 10 Mar, 2021
Novartis has announced that Singapore Health Sciences Authority (HSA) has approved Kymriah (tisagenlecleucel) as th...Read more
Setsuro Tech gets access to ERS Genomics’ CRISPR/Cas9 patent portfolio for Japan
Therapeutics | News | 0 Comment | 10 Mar, 2021
ERS Genomics Limited, which was formed to provide broad access to the foundational CRISPR/Cas9 intellectual property co-...Read more
Hong Kong unveils next-gen drug for cancers associated with Epstein–Barr virus
Therapeutics | News | 0 Comment | 03 Mar, 2021
A Hong Kong Baptist University-led (HKBU) research team has developed a novel drug which has the potential to ...Read more